Virtus LifeSci Biotech Products ETF
19 hedge funds and large institutions have $9.1M invested in Virtus LifeSci Biotech Products ETF in 2017 Q2 according to their latest regulatory filings, with 4 funds opening new positions, 5 increasing their positions, 5 reducing their positions, and 3 closing their positions.
New
Increased
Maintained
Reduced
Closed
more capital invested
Capital invested by funds: $ → $
more first-time investments, than exits
New positions opened: | Existing positions closed:
more ownership
Funds ownership: →
more funds holding
Funds holding: →
0% more repeat investments, than reductions
Existing positions increased: 5 | Existing positions reduced: 5
Holders
19
Holding in Top 10
–
Calls
–
Puts
–
Top Buyers
| 1 | +$1.03M | |
| 2 | +$863K | |
| 3 | +$715K | |
| 4 |
PAG
Private Advisor Group
Morristown,
New Jersey
|
+$415K |
| 5 |
VKH
Virtu KCG Holdings
New York
|
+$400K |
Top Sellers
| 1 | -$470K | |
| 2 | -$225K | |
| 3 | -$120K | |
| 4 |
UBS Group
Zurich,
Switzerland
|
-$99.6K |
| 5 |
FDCDDQ
Federation des caisses Desjardins du Quebec
Levis,
Quebec, Canada
|
-$48.6K |